A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/1994
03/01/1994	CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production
02/1994
02/26/1994	CA2104764A1 Method for the safe administration of fatty acids
02/26/1994	CA2104747A1 Method for the safe administration of fatty acids
02/23/1994	EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
02/23/1994	EP0461111B1 Treatment of osteoporosis
02/22/1994	CA2104567A1 Fatty acid treatment
02/22/1994	CA2103943A1 Composition and methods for the generation of bone
02/17/1994	WO1994003431A1 Isoserine derivatives and their use as leukotriene antagonists
02/17/1994	WO1994003201A1 Parathyroid hormone fragments and analogs
02/17/1994	CA2141588A1 Parathyroid hormone fragments and analogs
02/17/1994	CA2134565A1 Isoserine derivatives and their use as leukotriene antagonists
02/16/1994	EP0582643A1 Pyridazinone acetic acids
02/08/1994	US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer
02/03/1994	WO1994002510A2 Analogs of pth
02/03/1994	WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
02/03/1994	WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors
02/02/1994	EP0580738A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity.
02/02/1994	EP0580650A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof
01/1994
01/26/1994	EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use
01/26/1994	EP0579939A1 Phospholipid derivatives
01/26/1994	EP0579915A1 Pharmaceutical composition containing a-cis- o 13-cis-retinoic acid or acitretin and a vitamin D derivative
01/20/1994	WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
01/20/1994	WO1994001412A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
01/20/1994	CA2139307A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
01/19/1994	EP0579066A2 N-substituted anilines
01/19/1994	EP0578978A1 Dipeptide derivative and prophylactic or therapeutic agent for bone diseases containing same as active ingredient
01/18/1994	US5280106 Pentapeptide; collagenase inhibitor
01/18/1994	US5280040 Osteoporosis
01/16/1994	CA2099294A1 N-substituted anilines
01/12/1994	EP0578494A1 24-cyclopropane vitamin D derivatives
01/12/1994	EP0578083A2 Cyclic adhesion inhibitors
01/12/1994	CN1080531A Quick effect active ion calcium
01/12/1994	CN1080525A Pharmaceutical compositions
01/06/1994	WO1994000130A1 Compositions for the treatment of arthritis containing phosphonates and nsaids
01/06/1994	WO1994000129A1 Use of phosphonates for the treatment of osteoporosis
01/06/1994	WO1994000128A1 ORAL 1α-HYDROXYPREVITAMIN D
12/1993
12/29/1993	EP0575555A1 Protein-induced morphogenesis
12/23/1993	WO1993025667A1 D-enzyme compositions and methods of their use
12/23/1993	WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man
12/22/1993	CN1079732A Pharmaceutical compounds
12/14/1993	US5270300 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
12/09/1993	WO1993024500A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024499A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024498A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
12/09/1993	WO1993024497A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024496A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024495A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024494A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993	WO1993024491A1 Indolocarbazole imides and their use
12/09/1993	WO1993024131A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993	CA2136819A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/08/1993	EP0573392A1 Thiosemicarbazones derivatives and their use as pharmaceuticals
12/08/1993	EP0573133A1 Means for transdermal application of Gestoden
12/08/1993	EP0572537A1 Cytokine inhibitors
12/08/1993	EP0461218B1 Oxypurinol salt composition for oral administration for treating hyperurecemia
12/07/1993	US5268386 Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia
12/04/1993	CA2097485A1 Thiosemicarbazone derivatives
12/02/1993	DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571546A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity.
11/1993
11/30/1993	US5266564 Method for treating certain autoimmune diseases
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/24/1993	EP0570380A1 Novel methylenebisphosphonic acid derivatives
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/21/1993	CA2096196A1 Pharmaceutical compositions
11/18/1993	EP0570091A1 Anthraquinone derivatives, process for their preparation and their use as medicaments
11/16/1993	US5262565 Naphthalene derivatives
11/11/1993	WO1993022436A1 Lectin domain variants of selectin
11/11/1993	WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993	WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993	WO1993021907A1 Pharmaceutical preparation and process for its manufacture
11/09/1993	US5260422 MHC conjugates useful in ameliorating autoimmunity
11/09/1993	US5260322 Angiotension II antagonists in the treatment of hyperuricemia
11/03/1993	EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
11/03/1993	EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/02/1993	US5258377 2-spirocyclopropyl 4-acylcephems
11/02/1993	US5258371 Method to reduce connective tissue destruction
11/02/1993	CA2094332A1 Urokinase inhibitors
10/1993
10/28/1993	WO1993020827A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
10/27/1993	EP0567353A1 Use of 1-alpha,25-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
10/27/1993	EP0567107A1 Quinoline and quinazoline derivatives for treating arthritis
10/27/1993	EP0566919A1 2,4-dioxoimidazoline derivatives
10/27/1993	EP0566647A1 Improved humanized immunoglobulins
10/25/1993	CA2094774A1 Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor
10/19/1993	US5254594 Remedies for bone diseases
10/19/1993	US5254544 Anticholesterol
10/19/1993	CA1323366C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives
10/14/1993	WO1993019768A1 Self-assembling polynucleotide delivery system
10/13/1993	EP0564835A2 2,2-Disubstituted cephem sulphones
10/12/1993	US5252560 Cyclic imide derivatives, compositions and use
10/06/1993	EP0563107A1 Novel methylenebisphosphonic acid derivatives
10/06/1993	EP0563096A1 Novel methylenebisphosphonic acid derivatives
10/05/1993	CA1322719C Activator for osteoblast
09/1993
09/30/1993	WO1993018774A1 Use if estriol for treating climacteric osteoporosis
09/30/1993	WO1993016099A3 Dna sequences encoding novel growth/differentiation factors
09/29/1993	EP0561877A1 Compounds and compositions which inhibit bone resorption
09/29/1993	CN1076696A Pharmaceutical compounds
09/22/1993	EP0474712B1 Lysolecithin derivatives for treating autoimmune diseases
09/21/1993	US5246700 In patients suffering from malignant tumors, interleukin-4
09/16/1993	WO1993017684A2 Enantiomeric hydroxylated xanthine compounds

1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820